Serological and cellular inflammatory signatures in end‐stage kidney disease and latent tuberculosis

Abstract

ObjectivesTuberculosis comorbidity with chronic diseases including diabetes, HIV and chronic kidney disease is of rising concern. In particular, latent tuberculosis infection (LTBI) comorbidity with end‐stage kidney disease (ESKD) is associated with up to 52.5‐fold increased risk of TB reactivation to active tuberculosis infection (ATBI). The immunological mechanisms driving this significant rise in TB reactivation are poorly understood. To contribute to this understanding, we performed a comprehensive assessment of soluble and cellular immune features amongst a unique cohort of patients comorbid with ESKD and LTBI.MethodsWe assessed the plasma and cellular immune profiles from patients with and without ESKD and/or LTBI (N = 40). We characterised antibody glycosylation, serum complement and cytokine levels. We also assessed classical and non‐classical monocytes and T cells with flow cytometry. Using a systems‐based approach, we identified key immunological features that discriminate between the different disease states.ResultsIndividuals with ESKD exhibited a highly inflammatory plasma profile and an activated cellular state compared with those without ESKD, including higher levels of inflammatory antibody Fc glycosylation structures and activated CX3CR1+ monocytes that correlate with increased inflammatory plasma cytokines. Similar elevated inflammatory signatures were also observed in ESKD+/LTBI+ compared with ESKD−/LTBI+, suggesting that ESKD induces an overwhelming inflammatory immune state. In contrast, no significant inflammatory differences were observed when comparing LTBI+ and LTBI− individuals.ConclusionOur study highlights the highly inflammatory state induced by ESKD. We hypothesise that this inflammatory state could contribute to the increased risk of TB reactivation in ESKD patients.

Standardized Whole Blood Assay and Bead-Based Cytokine Profiling Reveal Commonalities and Diversity of the Response to Bacteria and TLR Ligands in Cattle

“…Much attention has also been paid to the characterization of pathogen-specific cytokine profiles in both human and veterinary medicine ( 12 , 48 , 49 ). Differences in pathogen-related cytokine profiles can be revealed by simple pairwise comparisons of absolute cytokine concentration across different diseases or stimulation conditions, but multidimensional data analysis often provides a more in-depth view ( 12 , 28 , 50 – 52 ). Among various statistical approaches, non-supervised Principal Component Analysis (PCA) has been the most extensively applied, while supervised approaches, namely, PLS-DA, Random Forest, and Support Vector Machine data analysis, have been less widely explored as a means to interpret cytokine profiling ( 45 , 53 – 56 ).…”

Lasting first impression: Pre-existing immunity restricts mucosal antibody responses during Omicron breakthrough

“…A Least Absolute Shrinkage and Selection Operator (LASSO) penalized logistic regression model was used to identify the minimal set of features that differentiated between COVID-19 recovered and COVID-19 vaccinated only vaccinees [20]. The feature selection stability was defined as the proportion of times that a feature was selected when the model was repeatedly fitted to 1000 resampled subsets of data as previously described [21]. Principal Component analysis (PCA) was then performed.…”

Leveraging Antibody, B Cell and Fc Receptor Interactions to Understand Heterogeneous Immune Responses in Tuberculosis

“…Both are enhanced with IgG purified from latent compared to active TB patients, implicating roles in potential protection for TB ( 16 ). If and how antibody glycosylation contributes to immune mediated outcomes in the context of HIV, diabetes and renal disease, the most significant risk factors for TB, remain uncharacterized ( 44 ). As biomarkers, direct comparison between Mtb reactive-IgG glycans and titers in a small cohort of individuals show that the former has enhanced ability to distinguish between latent and active TB ( 17 ).…”